Comparison of Detection Rate and Mutational Pattern of Drug-Resistant Mutations Between a Large Cohort of Genotype B and Genotype C Hepatitis B Virus-Infected Patients in North China

被引:15
作者
Li, Xiaodong [1 ]
Liu, Yan [1 ]
Xin, Shaojie [2 ]
Ji, Dong [2 ]
You, Shaoli [2 ]
Hu, Jinhua [2 ]
Zhao, Jun [2 ]
Wu, Jingjing [1 ]
Liao, Hao [1 ]
Zhang, Xin-Xin [3 ]
Xu, Dongping [1 ]
机构
[1] Beijing 302 Hosp, Res Ctr Clin & Translat Med, 100 Middle St,West 4th Ring Rd, Beijing 100039, Peoples R China
[2] Beijing 302 Hosp, Med Ctr Liver Failure, Beijing, Peoples R China
[3] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Infect Dis, 197 Rui Jin Second Rd, Shanghai 200025, Peoples R China
关键词
hepatitis B virus; drug resistance; genotype; MULTIDRUG-RESISTANCE; ADEFOVIR DIPIVOXIL; HBV; LAMIVUDINE; EVOLUTION; PROFILE; STRAIN; IMPACT; NAIVE;
D O I
10.1089/mdr.2016.0093
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The study aimed to investigate the association of prevalent genotypes in China (HBV/C and HBV/B) with HBV drug-resistant mutations. A total of 13,847 nucleos(t) ide analogue (NA)-treated patients with chronic HBV infection from North China were enrolled. HBV genotypes and resistant mutations were determined by direct sequencing and confirmed by clonal sequencing if necessary. HBV/B, HBV/C, and HBV/D occupied 14.3%, 84.9%, and 0.8% across the study population, respectively. NA usage had no significant difference between HBV/B- and HBV/C-infected patients. Lamivudine-resistant mutations were more frequently detected in HBV/C-infected patients, compared with HBV/B-infected patients (31.67% vs. 25.26%, p < 0.01). Adefovir- and entecavir-resistant mutation detection rates were similar, but the mutational pattern was different between the two genotypes. For adefovir-resistant mutations, HBV/C-infected patients had a higher detection rate of rtA181V (HBV/C 5.29% vs. HBV/B 1.36%, p < 0.01) and a lower detection rate of rtN236T (2.70% vs. 6.54%, p < 0.01). For entecavir-resistant mutations, HBV/C-infected patients had a higher detection rate of rtM204 V/ I+T184 substitution or S202G/C (3.66% vs. 2.16%, p < 0.01) and a lower detection rate of rtM204 V/I+M250 V/ I/L substitution (0.67% vs. 1.46%, p < 0.01). Multidrug-resistant mutations (defined as coexistence of mutation to nucleoside and nucleotide analogues) were detected in 104 patients. HBV/C-infected patients had a higher detection rate of multidrug-resistant mutation than HBV/B-infected patients (0.83% vs. 0.35%, p < 0.05). The study for the first time clarified that HBV/C-infected patients had a higher risk to develop multidrug-resistant mutations, compared with HBV/B-infected patients; and HBV/C-and HBV/B-infected patients had different inclinations in the ETV-resistant mutational pattern.
引用
收藏
页码:516 / 522
页数:7
相关论文
共 30 条
[1]   Hepatitis B virus infection from an evolutionary point of view: How viral, host, and environmental factors shape genotypes and subgenotypes [J].
Araujo, Natalia M. ;
Waizbort, Ricardo ;
Kay, Alan .
INFECTION GENETICS AND EVOLUTION, 2011, 11 (06) :1199-1207
[2]   Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir [J].
Brunelle, MN ;
Jacquard, AC ;
Pichoud, C ;
Durantel, D ;
Carrouée-Durantel, S ;
Villeneuve, JP ;
Trépo, C ;
Zoulim, F .
HEPATOLOGY, 2005, 41 (06) :1391-1398
[3]   A description of the hepatitis B virus genomic background in a high-prevalence area in China [J].
Chen, Xiaoming ;
Gao, Jie ;
Ji, Zhaohua ;
Zhang, Weilu ;
Zhang, Lei ;
Xu, Rui ;
Zhang, Jingxia ;
Li, Fei ;
Li, Shi ;
Hu, Shijie ;
Shang, Lei ;
Shao, ZhongJun ;
Yan, Yongping .
VIROLOGY JOURNAL, 2014, 11
[4]  
Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007
[5]  
GONZALEZ L, 2015, PLOS ONE, V0010
[6]   Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE) [J].
Hermans, Lucas Etienne ;
Svicher, Valentina ;
Pas, Suzan Diepstraten ;
Salpini, Romina ;
Alvarez, Marta ;
Ben Ari, Ziv ;
Boland, Greet ;
Bruzzone, Bianca ;
Coppola, Nicola ;
Seguin-Devaux, Carole ;
Dyda, Tomasz ;
Garcia, Federico ;
Kaiser, Rolf ;
Kose, Sukran ;
Krarup, Henrik ;
Lazarevic, Ivana ;
Lunar, Maja M. ;
Maylin, Sarah ;
Micheli, Valeria ;
Mor, Orna ;
Paraschiv, Simona ;
Paraskevis, Dimitrios ;
Poljak, Mario ;
Puchhammer-Stoeckl, Elisabeth ;
Simon, Francois ;
Stanojevic, Maja ;
Stene-Johansen, Kathrine ;
Tihic, Nijaz ;
Trimoulet, Pascale ;
Verheyen, Jens ;
Vince, Adriana ;
Weis, Nina ;
Yalcinkaya, Tulay ;
Lepej, Snjezana Zidovec ;
Perno, Carlo ;
Boucher, Charles A. B. ;
Wensing, Annemarie M. J. .
JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (01) :39-48
[7]   Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern [J].
Inoue, J. ;
Ueno, Y. ;
Wakui, Y. ;
Niitsuma, H. ;
Fukushima, K. ;
Yamagiwa, Y. ;
Shiina, M. ;
Kondo, Y. ;
Kakazu, E. ;
Tamai, K. ;
Obara, N. ;
Iwasaki, T. ;
Shimosegawa, T. .
JOURNAL OF VIRAL HEPATITIS, 2011, 18 (03) :206-215
[8]   Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection [J].
Li, Xiaodong ;
Liu, Yan ;
Zhao, Pan ;
Wang, Yan ;
Chen, Li ;
Xin, Shaojie ;
Zhang, Xin-Xin ;
Xu, Dongping .
ANTIVIRAL THERAPY, 2015, 20 (02) :141-147
[9]   Hepatitis B Virus (HBV) Subgenotypes C2 and B2 Differ in Lamivudine- and Adefovir-Resistance-Associated Mutational Patterns in HBV-Infected Chinese Patients [J].
Li, Xiaodong ;
Wang, Lin ;
Zhong, Yanwei ;
Wong, Vincent Wai-Sun ;
Xu, Zhihui ;
Liu, Yan ;
Li, Qinghong ;
Xin, Shaojie ;
Zhao, Jingmin ;
Xu, Dongping .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (12) :4363-4369
[10]   Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection [J].
Liu, Y. ;
Wang, C. ;
Zhong, Y. ;
Li, X. ;
Dai, J. ;
Ren, X. ;
Xu, Z. ;
Li, L. ;
Yao, Z. ;
Ji, D. ;
Wang, L. ;
Zhang, L. ;
Wong, V. W. -S. ;
Zoulim, F. ;
Xu, D. .
JOURNAL OF VIRAL HEPATITIS, 2011, 18 (04) :e29-e39